AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 34933416
Drug: Testosterone replacement
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone replacement therapy (testosterone undecanoate injection three times/6 months, n=20)
Trial: 35241720
Drug: Empagliflozin 25
RxNorm normalized name: empagliflozin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 25 mg QD
Trial: 33407599
Drug: Whole tomato
RxNorm normalized name: Tomato
DrugBank: Tomato (DB10573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole tomato food supplement (WTFS) 5g daily for 2 months
Trial: 33242163
Drug: Systemic treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic treatment (ST)
Trial: 35488544
Drug: HEV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HEV vaccine administered at 0, 1, and 6 months
Trial: 33212540
Drug: Low-Dose Computed
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-Dose Computed Tomography (LDCT) screening
Trial: 32448257
Drug: 600mcg oral
RxNorm normalized name: Fentanyl Citrate 600mcg Oral lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600mcg oral misoprostol given to all women after delivery (primary prevention)
Trial: 36326117
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of RAS inhibitors
Trial: 32543080
Drug: Trigone-involved Botox
RxNorm normalized name: Botox
DrugBank: DaxibotulinumtoxinA (DB17929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trigone-involved Botox injection (100 IU intradetrusal)
Trial: 32484940
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate (FF) 100 μg/d
Trial: 35334862
Drug: Low-dose whey
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose whey protein concentrate (WPC)
Trial: 32178765
Drug: Guselkumab 100
RxNorm normalized name: guselkumab 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guselkumab 100 mg every 4 weeks
Trial: 39083288
Drug: Guselkumab 100
RxNorm normalized name: guselkumab 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guselkumab 100 mg every 8 weeks
Trial: 32856211
Drug: Immune-suppressive therapy
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immune-suppressive therapy
Trial: 36458679
Drug: Desidustat 50
RxNorm normalized name: Desidustat
DrugBank: Desidustat (DB16135)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desidustat 50 mg orally
Trial: 38133925
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin
Trial: 35148706
Drug: Acceptance and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance and Commitment Therapy (ACT) counseling in 8 sessions of 60 to 90 minutes
Trial: 34914243
Drug: Low-dose dexmedetomidine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dexmedetomidine + Hydromorphone (DM + HM)
Trial: 33769656
Drug: Henagliflozin 5
RxNorm normalized name: BEXAGLIFLOZIN
DrugBank: Bexagliflozin (DB12236)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Henagliflozin 5 mg
Trial: 34489928
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (NAC-AC) without DCs (control group)
Trial: 37477771
Drug: Zolpidem 10
RxNorm normalized name: zolpidem 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 10 mg
Trial: 34275122
Drug: Baricitinib 1
RxNorm normalized name: baricitinib 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baricitinib 1 mg
Trial: 33058553
Drug: Miglitol reference
RxNorm normalized name: Miglitol
DrugBank: Miglitol (DB00491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Miglitol reference formulation/sucrose coadministration
Trial: 33058553
Drug: Sucrose administration
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose administration alone
Trial: 33837482
Drug: Cyclosporine 5
RxNorm normalized name: cyclosporine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine 5 mg/(kg·d) plus andriol 160 mg/d
Trial: 36152639
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (100 U/mL)
Trial: 38745322
Drug: Mirror Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirror Therapy (MT)
Trial: 33768368
Drug: Fluticasone Propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone Propionate Dry Powder Inhaler A-4.5 (500 μg)
Trial: 33768368
Drug: Fluticasone Propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone Propionate Dry Powder Inhaler C-3.7 (500 μg)
Trial: 34293528
Drug: Subcutaneous immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous immunoglobulin (IgPro20) at 0.2 g/kg
Trial: 32780166
Drug: Intravenous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vitamin C (50 mg/kg, maximum single dose 3 g) and thiamine (200 mg) every 12 h for 48 h
Trial: 39707407
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (placebo)
Trial: 38195586
Drug: Intravenous aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous aspirin
Trial: 38884900
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of physician's choice (TPC)
Trial: 36164012
Drug: Danazol (DAN)
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol (DAN) 600 mg QD
Trial: 36164012
Drug: Momelotinib (MMB)
RxNorm normalized name: momelotinib
DrugBank: Momelotinib (DB11763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Momelotinib (MMB) 200 mg QD
Trial: 34473249
Drug: Early rhythm
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early rhythm control therapy (antiarrhythmic drugs and AF ablation)
Trial: 34473249
Drug: Early rhythm
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early rhythm control therapy
Trial: 34469706
Drug: 14 days
RxNorm normalized name: ponesimod
DrugBank: Ponesimod (DB12016)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 14 days of intravenous antimicrobials
Trial: 34404592
Drug: Maintaining serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintaining serum potassium at ≥4.5 mEq/L
Trial: 32048274
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of iv dexamethasone 24 mg
Trial: 39147988
Drug: Allopurinol administration
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol administration
Trial: 38584159
Drug: Candesartan 8
RxNorm normalized name: candesartan 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 8 mg
Trial: 35405955
Drug: Isotretinoin combined
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotretinoin combined with evening primrose oil (4 × 510 mg/day)
Trial: 35361328
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (FKB238, EU-bevacizumab, US-bevacizumab)
Trial: 37449048
Drug: Simvastatin 80
RxNorm normalized name: simvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 80 mg/day
Trial: 35101364
Drug: Pertuzumab plus
RxNorm normalized name: Pertuzumab
DrugBank: Pertuzumab (DB06366)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pertuzumab plus trastuzumab plus metronomic chemotherapy (TPM)
Trial: 36026559
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine - two injections once every two weeks
Trial: 35172876
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride 0.9% solution (placebo, 0.1-0.3 ml per injection)
Trial: 35468803
Drug: ANI group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ANI group (goal-directed analgesia targeting 50-80 ANI range with prophylactic morphine if ANI < 50)
Trial: 35341360
Drug: Mirror therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirror therapy (MT)
Trial: 32664057
Drug: High-dissolution turmeric-sesame
RxNorm normalized name: Sesame Oil
DrugBank: Sesame oil (DB11172)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dissolution turmeric-sesame formulation (Rhuleave-K; 1,000 mg/d)
Trial: 37339352
Drug: Low Level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low Level Laser Therapy (LLLT)
Trial: 33384385
Drug: SAFE intervention
RxNorm normalized name: Safe-Guard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAFE intervention (five-session family therapy-based intervention delivered over 16 weeks)
Trial: 37025023
Drug: Aspirin 81
RxNorm normalized name: aspirin 81 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 81 mg
Trial: 32468508
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of hyperimmune plasma from convalescent donors of COVID-19
Trial: 35252940
Drug: Any hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Any hormone or SHBG
Trial: 34716885
Drug: Reminiscence therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reminiscence therapy involved care (RTIC)
Trial: 34264305
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg once daily for 2 years
Trial: 35172056
Drug: EDP-938 300
RxNorm normalized name: INDIGOFERA TINCTORIA LEAF 0.999 in 100 g TOPICAL POWDER [EDP INDIGO]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EDP-938 300 mg once daily after a 600 mg loading dose
Trial: 33044356
Drug: Trazodone 50
RxNorm normalized name: traZODone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trazodone 50 mg daily for 5 days
Trial: 35300246
Drug: Trimodal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimodal therapy consisting of IMRT, gemcitabine and cetuximab
Trial: 32616489
Drug: Placebo, one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, one tablet each day for a total duration of 6 months
Trial: 36155150
Drug: l-carnitine
RxNorm normalized name: L-Carnitine
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: l-carnitine
Trial: 39151647
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy
Trial: 34756178
Drug: IL-1 blockade
RxNorm normalized name: IL-1 TRAP
DrugBank: Rilonacept (DB06372)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-1 blockade (anakinra 100 mg subcutaneously once daily for 28 days)
Trial: 37579130
Drug: Selective Serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective Serotonin Reuptake Inhibitors (SSRIs)
Trial: 37028515
Drug: Best available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Best available therapy (BAT)
Trial: 34133205
Drug: Standard-dose gadoterate
RxNorm normalized name: GADOTERATE
DrugBank: Gadoteric acid (DB09132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose gadoterate
Trial: 34101892
Drug: Rivoceranib 201
RxNorm normalized name: Rivoceranib
DrugBank: Rivoceranib (DB14765)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivoceranib 201 mg without food
Trial: 34101892
Drug: Rivoceranib 81
RxNorm normalized name: Rivoceranib
DrugBank: Rivoceranib (DB14765)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivoceranib 81 mg with food
Trial: 34101892
Drug: Rivoceranib 81
RxNorm normalized name: Rivoceranib
DrugBank: Rivoceranib (DB14765)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivoceranib 81 mg without food
Trial: 37951571
Drug: Omalizumab treatment
RxNorm normalized name: Omalizumab
DrugBank: Omalizumab (DB00043)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Omalizumab treatment
Trial: 36174602
Drug: Higher enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher enoxaparin doses
Trial: 34400254
Drug: N-of-1 trial
RxNorm normalized name: (Alginate)n+1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-of-1 trial treatment regimen
Trial: 38057919
Drug: BCG vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccine
Trial: 36214032
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (120 kVp, 370 mgI/ml CM)
Trial: 34674645
Drug: Weekly multidisciplinary
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly multidisciplinary team‐led deprescribing rounds (using five steps of deprescribing)
Trial: 34582035
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA)
Trial: 32505790
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of OES and HYbiopsy
Trial: 35836116
Drug: ESP block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ESP block with 0.375% ropivacaine (0.4 mL/kg)
Trial: 35287254
Drug: Thoracic radiotherapy
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic radiotherapy dose >54 Gy
Trial: 37304043
Drug: Ranibizumab 0.5
RxNorm normalized name: RANIBIZUMAB 0.5MG/0.05ML INJ,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranibizumab 0.5 mg
Trial: 34416778
Drug: Ibuprofen suppository
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen suppository
Trial: 34022840
Drug: Digital alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digital alcohol moderation intervention + Treatment as Usual (TAU)
Trial: 35022886
Drug: Life-sustaining treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Life-sustaining treatment (LST)
Trial: 35747181
Drug: 2-dose measles
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-dose measles vaccination (MV) at 4 and 9 months
Trial: 34453262
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate 0.025% formulation 13
Trial: 33319949
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous morphine analgesia
Trial: 39516087
Drug: Best Available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Best Available Therapy (BAT)
Trial: 38832995
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of adenosine
Trial: 32128615
Drug: Aprepitant (APR)
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprepitant (APR) 125 mg on day 1 and 80 mg on days 2-3
Trial: 33181328
Drug: Favipiravir combined
RxNorm normalized name: favipiravir
DrugBank: Favipiravir (DB12466)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Favipiravir combined with inhaled interferon beta-1b
Trial: 39641404
Drug: Daridorexant 50
RxNorm normalized name: daridorexant 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daridorexant 50 mg
Trial: 32341187
Drug: Daridorexant 10
RxNorm normalized name: Daridorexant
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daridorexant 10 mg
Trial: 35357079
Drug: Low-dose Lomecel-B
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose Lomecel-B
Trial: 32815805
Drug: Locked plating
RxNorm normalized name: platinic chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Locked plating followed by intraoperatively performed glenohumeral joint lavage (group L)
Trial: 32815805
Drug: Avascular necrosis
RxNorm normalized name: endothelial growth factor A, vascular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avascular necrosis in group L
Trial: 32293522
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root-planing treatment
Trial: 32035551
Drug: Biological mesh
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological mesh reinforcement
Trial: 35233908
Drug: ertugliflozin 5
RxNorm normalized name: ertugliflozin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ertugliflozin 5 mg
Trial: 32493494
Drug: Hydroxychloroquine 200mg
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine 200mg once daily for two months (HC group)
Trial: 33899214
Drug: Dexamethasone 20
RxNorm normalized name: dexamethasone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 20 mg pre-operatively
Trial: 32268344
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of levodopa
Trial: 34060339
Drug: Penile traction
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penile traction therapy
Trial: 35650437
Drug: Combination broadly
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination broadly neutralizing monoclonal antibodies (3BNC117 and 10-1074), administered up to 8 infusions over 24 weeks.
Trial: 32212275
Drug: TransCon PTH
RxNorm normalized name: TransCon PTH
DrugBank: Palopegteriparatide (DB18676)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TransCon PTH (administered daily for 10 days)
Trial: 34449946
Drug: Vitrification treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitrification treatment
Trial: 35349757
Drug: Ganciclovir treatment
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ganciclovir treatment
Trial: 39715755
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (chemotherapy alone)
Trial: 34403326
Drug: Isoniazid 5
RxNorm normalized name: isoniazid 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoniazid 5 mg/kg (normal dose)
Trial: 32021407
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg/day
Trial: 34543941
Drug: Chemotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy + Denosumab (subgroup: squamous histology)
Trial: 34116270
Drug: Disease-free survival
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease-free survival (DFS) in hormone receptor positive patients
Trial: 32463279
Drug: IV nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV nicotine (0.5 mg/70 kg)
Trial: 33249142
Drug: Low-Dose Radiation
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-Dose Radiation Therapy (LD-RT) at 100 cGy to total lungs in a single fraction
Trial: 32921155
Drug: Injection dexamethasone
RxNorm normalized name: dexamethasone Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection dexamethasone alone (group II)